Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-25), Chongqing Zhifei Biological Products Co's Beta is 1.7328.
Chongqing Zhifei Biological Products Co (SZSE:300122) Beta Explanation
Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.
Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
Chongqing Zhifei Biological Products Co Beta Related Terms
Chongqing Zhifei Biological Products Co Beta Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chongqing Zhifei Biological Products Co Beta Chart
Chongqing Zhifei Biological Products Co Annual Data
For the Biotechnology subindustry, Chongqing Zhifei Biological Products Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chongqing Zhifei Biological Products Co Beta vs Biotechnology Industry
Chongqing Zhifei Biological Products Co Beta Calculation
Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.
Chongqing Zhifei Biological Products Co (SZSE:300122) has a Beta of 1.7328 as of Aug. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Chongqing Zhifei Biological Products Co and its competitors.
Is Chongqing Zhifei Biological Products Co's Beta too high?
Chongqing Zhifei Biological Products Co's current Beta is 1.7328. Overall, Chongqing Zhifei Biological Products Co has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Chongqing Zhifei Biological Products Co's Beta compare to VRTX and REGN?
Chongqing Zhifei Biological Products Co's Beta of 1.7328 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Chongqing Zhifei Biological Products Co and its competitors. Chongqing Zhifei Biological Products Co's current Beta is 1.7328. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chongqing Zhifei Biological Products Co stock overvalued right now?
Based on GuruFocus' analysis, Chongqing Zhifei Biological Products Co (SZSE:300122) is currently considered Fairly Valued. The stock's GF Value™ is ¥13.99, compared to a current price of ¥14.39 — trading 2.9% above its estimated fair value. The current Beta is 1.7328. Chongqing Zhifei Biological Products Co's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Chongqing Zhifei Biological Products Co (SZSE:300122), the current Beta is 1.7328 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chongqing Zhifei Biological Products Co (SZSE:300122) Overvalued in 2026?
Based on GuruFocus' analysis, Chongqing Zhifei Biological Products Co stock appears to be overvalued.
The current stock price of ¥14.39 is trading 2.9% above its estimated GF Value™ of ¥13.99.
GuruFocus considers Chongqing Zhifei Biological Products Co to be Fairly Valued.
Key valuation signals for SZSE:300122:
Beta: 1.7328
GF Value™: ¥13.99 vs. price of ¥14.39 (2.9% above fair value)
No single metric tells the full story. See the SZSE:300122 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chongqing Zhifei Biological Products Co Ltd is engaged in research and development, production, and sales of vaccines and biological products. The company's main products include bacterial vaccines for the prevention of meningitis and pneumonia-based bacteria, biological products for the prevention and treatment of tuberculosis, viral vaccines for the prevention of rabies virus, influenza virus, and other viruses, general drugs and other biological products, among others.
65GF Score
Get the complete analysis for SZSE:300122
Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:300122 has been successfully added to your 
